CO 036: DRUG USE IN PREGNANT WOMEN

Excerpt:


J Pharm Pharmacogn Res 2(Suppl. 1): S19, 2014 Special supplement with the abstract book of LATINFARMA 2013 Oral Communication CO 036: DRUG USE IN PREGNANT WOMEN Viroga S, Ramos C, Artagaveytia P, Speranza N, Tamosiunas G. Department of Pharmacology and Therapeutics, School of Medicine, UdelaR, Uruguay. Abstract Introduction: There are few local data on drug … Continue reading CO 036: DRUG USE IN PREGNANT WOMEN

J Pharm Pharmacogn Res 2(Suppl. 1): S19, 2014

Special supplement with the abstract book of LATINFARMA 2013

Oral Communication

CO 036: DRUG USE IN PREGNANT WOMEN

Viroga S, Ramos C, Artagaveytia P, Speranza N, Tamosiunas G.

Department of Pharmacology and Therapeutics, School of Medicine, UdelaR, Uruguay.
Abstract

Introduction: There are few local data on drug use during pregnancy in our country. The selection of drugs in pregnancy must be based on efficacy and safety, taking into account the pharmacokinetic and pharmacodynamic changes that occur during pregnancy and the potential harm to the fetus.

Objective: To study the drug consumption profile in pregnant women in a maternal referential hospital in Uruguay.

Methods: Descriptional study, survey conducted by students of the College of Midwives from July to November 2010. The variables considered were: medications used, frequency of use of medications, source of prescription, teratogenic risk and use of abuse substances.

Results: 126 pregnant women (96.9%) used medications during their pregnancy. 364 drugs were used, including 64 active principles. The average use of drugs was 2.8 per woman. The most used drugs were iron, folic acid and dexamethasone. The 11.5% of the drugs were self prescribed (93% were NSAIDs). 37% of pregnant women consumed some abuse substance and 43% of those were consumed during the first trimester. Most used drugs corresponded to the B FDA category.

Conclusions: Despite popular belief, there is a high percentage of pregnant women using drugs. Contrary to the idea that drugs should not be used in pregnant women, there are certain drugs approved for its use in this population. The high percentage use of abuse substances, especially during the first trimester, is a concerning situation. The sample included in our study is not representative of the general population, but it allowed a situational assessment, pharmacoepidemiology important for our country. A future study with a larger number of patients will be needed. This study also resulted in the creation of research lines and allowed students to be involved in investigational activities.

Ageratum conyzoides and eggshell membrane hydrolysates in chronic inflammation
J. Pharm. Pharmacogn. Res., vol. 12, no. 5, pp. 972-993, Sep-Oct 2024. DOI: https://doi.org/10.56499/jppres24.1956_12.5.972 Original Article Anti-inflammatory effect of the mixture of Ageratum conyzoides L. extract and eggshell membrane hydrolysates and in silico active compound predictions [Efecto antiinflamatorio de la mezcla de extracto de Ageratum conyzoides L. e hidrolizados de membrana de cáscara de huevo, … Continue reading Ageratum conyzoides and eggshell membrane hydrolysates in chronic inflammation
SS-31 for diabetic nephropathy
J. Pharm. Pharmacogn. Res., vol. 12, no. 5, pp. 956-971, Sep-Oct 2024. DOI: https://doi.org/10.56499/jppres23.1904_12.5.956 Review SS-31 protects diabetic nephropathy progression: A systematic review of in vivo and in vitro studies [El SS-31 protege la progresión de la nefropatía diabética: Una revisión sistemática de estudios in vivo e in vitro] Jonathan Christianto Sutadji1#, Dian Anggraini Permatasari … Continue reading SS-31 for diabetic nephropathy
Hypertension knowledge and its associated factors in primary care
J. Pharm. Pharmacogn. Res., vol. 12, no. 5, pp. 943-955, Sep-Oct 2024. DOI: https://doi.org/10.56499/jppres24.1955_12.5.943 Original Article Hypertension knowledge and its associated factors among hypertensive patients in primary care settings in Central Vietnam: A cross-sectional study [Conocimiento de la hipertensión y sus factores asociados entre pacientes hipertensos en entornos de atención primaria en el centro de … Continue reading Hypertension knowledge and its associated factors in primary care

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio